Technical analysis of Coya Therapeutics, Inc. (COYA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies.
Price Performance
| 1 month | -9.35% |
| 3 months | -9.35% |
| Year-to-date | -23.10% |
| 1 year | -17.56% |
| 3 years | +6.70% |
52-Week Range
| 52-week High | $7.75 |
| 52-week Low | $3.71 |
| Avg Volume (90d) | 180K |
Technical Indicators
| SMA 50 | $4.64 |
| SMA 200 | $4.81 |
| Beta | 0.52 |
| 30-day Volatility (annualised) | 46.8% |
| Price vs SMA 50 | -3.8% |
| Price vs SMA 200 | -7.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $6.32 | |
| 2025-11 | $6.51 | +3.0% |
| 2025-12 | $5.80 | -10.9% |
| 2026-01 | $4.65 | -19.8% |
| 2026-02 | $4.96 | +6.7% |
| 2026-03 | $3.94 | -20.6% |
| 2026-04 | $4.23 | +7.4% |
| 2026-05 | $4.82 | +13.9% |
| 2026-06 | $5.85 | +21.4% |
| 2026-07 | $4.19 | -28.4% |
| 2026-08 | $4.56 | +8.8% |
| 2026-09 | $4.46 | -2.2% |
Price
| Price | $4.46 |
| Market Cap | $105M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.00 |
| EV / EBITDA | 1951.45 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 13.40 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 6.55 |